Exact Mass: 507.1529

Exact Mass Matches: 507.1529

Found 33 metabolites which its exact mass value is equals to given mass value 507.1529, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

POLYOXIN B

2-[(2-amino-5-carbamoyloxy-3,4-dihydroxy-pentanoyl)amino]-2-[(2R,3S,4R,5R)-3,4-dihydroxy-5-[5-(hydroxymethyl)-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]acetic acid

C17H25N5O13 (507.1449)

2-Decarboxybetanin

(1Z)-1-{2-[(4E)-2,6-dicarboxy-1,2,3,4-tetrahydropyridin-4-ylidene]ethylidene}-6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-1λ⁵-indol-1-ylium

C23H27N2O11+ (507.1615)

2-Decarboxybetanin is found in root vegetables. 2-Decarboxybetanin is a constituent of Beta vulgaris Constituent of Beta vulgaris. 2-Decarboxybetanin is found in root vegetables.

Benzamide, 5-((1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl)dimethoxymethyl)-2-chloro-

C27H26ClN3O5 (507.1561)

Cys Cys Pro Trp

(2S)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C22H29N5O5S2 (507.161)

Cys Cys Trp Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C22H29N5O5S2 (507.161)

Cys Pro Cys Trp

(2S)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C22H29N5O5S2 (507.161)

Cys Pro Trp Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

Cys Trp Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C22H29N5O5S2 (507.161)

Cys Trp Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

Pro Cys Cys Trp

(2S)-3-(1H-indol-3-yl)-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C22H29N5O5S2 (507.161)

Pro Cys Trp Cys

(2R)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

Pro Trp Cys Cys

(2R)-2-[(2R)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

Trp Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C22H29N5O5S2 (507.161)

Trp Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

Trp Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C22H29N5O5S2 (507.161)

2-Decarboxybetanin

(1E)-1-{2-[(4E)-2,6-dicarboxy-1,2,3,4-tetrahydropyridin-4-ylidene]ethylidene}-6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-1$l^{5}-indol-1-ylium

C23H27N2O11 (507.1615)

Hirsutidin 3-glucoside

C24H27O12+ (507.1502)

Benzenesulfonamide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-

C25H25N5O5S (507.1576)

5-chloro-N-[(2R)-2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]propyl]-2-methoxybenzamide

C24H30ClN3O5S (507.1595)

2-Decarboxybetanin

C23H27N2O11+ (507.1615)

Elcubragistat

C20H22F9N3O2 (507.1568)

Elcubragistat (ABX-1431) is a highly potent, selective, and orally available, CNS-penetrant monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 14 nM.

(3s,6r)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione

(3s,6r)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione

C27H25NO9 (507.1529)

(2r)-n-(2-{[2-({2,6-dihydroxy-3h-naphtho[2,1-b][1,4]thiazin-5-yl}sulfanyl)ethyl]-c-hydroxycarbonimidoyl}ethyl)-2,4-dihydroxy-3,3-dimethylbutanimidic acid

C23H29N3O6S2 (507.1498)

(s)-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid

C17H25N5O13 (507.1449)

(3s,6s)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione

(3s,6s)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione

C27H25NO9 (507.1529)

{[2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid

C17H25N5O13 (507.1449)

19-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-3,9-dimethyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione

C27H25NO9 (507.1529)

(1s,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12-trihydroxy-13-{[(2e)-2-methylbut-2-enoyl]oxy}-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylic acid

C21H25N5O10 (507.1601)

[5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-7-ylidene](methyl)oxidanium

[C24H27O12]+ (507.1502)